A Phase III Trial of e-TNS for the Acute Treatment of Migraine

NACompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

January 11, 2019

Study Completion Date

January 11, 2019

Conditions
Migraine
Interventions
DEVICE

Verum Cefaly® Abortive Program device

The Cefaly® Abortive Program device is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as external Trigeminal Nerve Stimulation (e-TNS). The Verum Cefaly® Abortive Program device will deliver verum external trigeminal nerve stimulation.

DEVICE

Sham Cefaly® Abortive Program device

The Cefaly® Abortive Program device is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as external Trigeminal Nerve Stimulation (e-TNS). The Sham Cefaly® Abortive Program device will deliver sham external trigeminal nerve stimulation.

Trial Locations (10)

14609

Rochester Clinical Research, Rochester

20854

Meridian Clinical Research (Rockville Neurology), Rockville

29464

Coastal Carolina Research Center, Mt. Pleasant

31406

Meridian Clinical Research (Savannah Neurology), Savannah

33409

Palm Beach Research Center, West Palm Beach

44122

Rapid Medical Research Inc., Cleveland

85283

Clinical Research Consortium, Tempe

89119

Clinical Research Consortium, Las Vegas

91316

Pharmacology Research Institute, Encino

06519

Yale University, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cefaly Technology

INDUSTRY

NCT03465904 - A Phase III Trial of e-TNS for the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter